These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35599266)

  • 21. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
    Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
    Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
    Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
    Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
    Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy.
    Al-Omair A; Masucci L; Masson-Cote L; Campbell M; Atenafu EG; Parent A; Letourneau D; Yu E; Rampersaud R; Massicotte E; Lewis S; Yee A; Thibault I; Fehlings MG; Sahgal A
    Neuro Oncol; 2013 Oct; 15(10):1413-9. PubMed ID: 24057886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative Stereotactic Body Radiotherapy for Spinal Metastasis and Predictors of Local Control.
    Blakaj DM; Palmer JD; Dibs K; Olausson A; Bourekas EC; Boulter D; Ayan AS; Cochran E; Marras WS; Mageswaran P; Katzir M; Yildiz VO; Grecula J; Arnett A; Raval R; Scharschmidt T; Elder JB; Lonser R; Chakravarti A; Mendel E
    Neurosurgery; 2021 Apr; 88(5):1021-1027. PubMed ID: 33575784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases.
    Mantel F; Glatz S; Toussaint A; Flentje M; Guckenberger M
    Strahlenther Onkol; 2014 Nov; 190(12):1141-8. PubMed ID: 24969225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
    Guckenberger M; Mantel F; Sweeney RA; Hawkins M; Belderbos J; Ahmed M; Andratschke N; Madani I; Flentje M
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):348-357. PubMed ID: 33412262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mature Imaging-Based Outcomes Supporting Local Control for Complex Reirradiation Salvage Spine Stereotactic Body Radiotherapy.
    Detsky JS; Nguyen TK; Lee Y; Atenafu E; Maralani P; Husain Z; Tseng CL; Myrehaug S; Soliman H; Sahgal A
    Neurosurgery; 2020 Sep; 87(4):816-822. PubMed ID: 32374852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
    Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F
    Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
    Leeman JE; Bilsky M; Laufer I; Folkert MR; Taunk NK; Osborne JR; Arevalo-Perez J; Zatcky J; Alektiar KM; Yamada Y; Spratt DE
    J Neurosurg Spine; 2016 Jul; 25(1):52-8. PubMed ID: 26943256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative dose, toxicity, and outcomes of spinal metastases re-irradiation : Systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Pontoriero A; Lillo S; Caravatta L; Bellafiore F; Longo S; Lattanzi E; Parisi S; Fiorica F; Massaccesi M
    Strahlenther Onkol; 2021 May; 197(5):369-384. PubMed ID: 33635395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
    Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
    J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials.
    Tao R; Bishop AJ; Brownlee Z; Allen PK; Settle SH; Chang EL; Wang X; Amini B; Tannir NM; Tatsui C; Rhines LD; Brown PD; Ghia AJ
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1405-1413. PubMed ID: 27209509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic body radiotherapy with helical tomotherapy for pain palliation in spine metastasis.
    Kim MS; Keum KC; Cha JH; Kim JH; Seong JS; Lee CG; Nam KC; Koom WS
    Technol Cancer Res Treat; 2013 Aug; 12(4):363-70. PubMed ID: 23448578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local Control.
    Abugharib A; Zeng KL; Tseng CL; Soliman H; Myrehaug S; Husain Z; Maralani PJ; Larouche J; Cheung P; Emmenegger U; Atenafu EG; Sahgal A; Detsky JS
    Neurosurgery; 2022 Jun; 90(6):743-749. PubMed ID: 35343467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases.
    Spratt DE; Arevalo-Perez J; Leeman JE; Gerber NK; Folkert M; Taunk NK; Alektiar KM; Karimi S; Lyo JK; Tap WD; Bilsky MH; Laufer I; Yamada Y; Osborne JR
    Spine J; 2016 Mar; 16(3):291-8. PubMed ID: 26325017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosurgery for Treatment of Renal Cell Metastases to Spine: A Systematic Review of the Literature.
    Smith BW; Joseph JR; Saadeh YS; La Marca F; Szerlip NJ; Schermerhorn TC; Spratt DE; Younge KC; Park P
    World Neurosurg; 2018 Jan; 109():e502-e509. PubMed ID: 29038086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Clinical Outcomes Stratified by Target Delineation for Patients Undergoing Stereotactic Body Radiotherapy for Spinal Metastases.
    Attiah M; Sandler K; Medina R; Gaonkar B; McArthur D; Farha G; Selch M; De Salles A; Tenn S; Agazaryan N; Lee P; Steinberg M; Lu D; Macyszyn L; Kaprealian T
    World Neurosurg; 2020 Apr; 136():e68-e74. PubMed ID: 31733382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group.
    Chang UK; Cho WI; Kim MS; Cho CK; Lee DH; Rhee CH
    Acta Oncol; 2012 May; 51(5):589-95. PubMed ID: 22414095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.